COMMON WARTS (VERRUCA VULGARIS)
Clinical trials for COMMON WARTS (VERRUCA VULGARIS) explained in plain language.
Never miss a new study
Get alerted when new COMMON WARTS (VERRUCA VULGARIS) trials appear
Sign up with your email to follow new studies for COMMON WARTS (VERRUCA VULGARIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New wart treatment seeks final approval in major trial
Disease control Recruiting nowThis study is testing a topical liquid called YCANTH to see if it can safely and effectively clear common warts. About 300 people aged 2 and up with common warts will have the treatment or a placebo applied to their warts every few weeks. The main goal is to see how many people h…
Matched conditions: COMMON WARTS (VERRUCA VULGARIS)
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Wart wars: vitamin d shots battle antiviral injections in skin study
Disease control Recruiting nowThis study tests whether injecting vitamin D3 or the antiviral drug acyclovir directly into skin warts helps clear them. Researchers will compare both treatments in 40 people with common, plantar, or flat warts to see which works better and causes fewer side effects. Participants…
Matched conditions: COMMON WARTS (VERRUCA VULGARIS)
Phase: PHASE4 • Sponsor: Riphah International University • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC